Literature DB >> 9089629

Specific inhibition of the cGMP-inhibited cAMP phosphodiesterase blocks the insulin-like antilipolytic effect of growth hormone in rat adipocytes.

H Eriksson1, H Tornqvist.   

Abstract

Growth hormone (GH) exerts acute insulin-like effects, such as increased lipogenesis and inhibition of catecholamine-induced lipolysis, in rat adipocytes that have not been exposed to GH during the preceding three hours. We found that OPC3911, a highly specific inhibitor of the cGMP-inhibited cAMP phosphodiesterase, completely blocked the antilipolytic but not the lipogenic effect of GH. This indicates that the antilipolytic effect of GH is mediated through activation of this phosphodiesterase leading to reduction of cAMP levels in the same manner as has been shown for insulin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089629     DOI: 10.1023/a:1006886509892

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  A simple free fat cell bioassay for insulin.

Authors:  A J Moody; M A Stan; M Stan; J Gliemann
Journal:  Horm Metab Res       Date:  1974-01       Impact factor: 2.936

2.  Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol.

Authors:  T Rahn; L Rönnstrand; M J Leroy; C Wernstedt; H Tornqvist; V C Manganiello; P Belfrage; E Degerman
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

Review 3.  Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.

Authors:  V C Manganiello; T Murata; M Taira; P Belfrage; E Degerman
Journal:  Arch Biochem Biophys       Date:  1995-09-10       Impact factor: 4.013

4.  Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin.

Authors:  H Eriksson; M Ridderstråle; E Degerman; D Ekholm; C J Smith; V C Manganiello; P Belfrage; H Tornqvist
Journal:  Biochim Biophys Acta       Date:  1995-04-06

5.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.

Authors:  T Okada; Y Kawano; T Sakakibara; O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

6.  Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin.

Authors:  T Rahn; M Ridderstråle; H Tornqvist; V Manganiello; G Fredrikson; P Belfrage; E Degerman
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

7.  Effects of preincubation on the ability of rat adipocytes to bind and respond to growth hormone.

Authors:  S Edén; J Schwartz; J L Kostyo
Journal:  Endocrinology       Date:  1982-11       Impact factor: 4.736

8.  Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.

Authors:  M L Elks; V C Manganiello
Journal:  Endocrinology       Date:  1985-05       Impact factor: 4.736

9.  Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes.

Authors:  M Ridderstråle; E Degerman; H Tornqvist
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

10.  Separation of early and late responses of adipose tissue to growth hormone.

Authors:  H M Goodman
Journal:  Endocrinology       Date:  1981-07       Impact factor: 4.736

View more
  1 in total

1.  Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.

Authors:  S Resjö; A Oknianska; S Zolnierowicz; V Manganiello; E Degerman
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.